In order to explore the mechanism by which GPR160 knockdown suppressed the growth of prostate cancer cells both in vivo and in vitro, Affymetrix GeneChip was applied to scramble- and ShGPR160-treated PC-3 cells to study changes of gene expression profile upon GPR160 silencing. This evidence concerns the gene GPR160 and prostate carcinoma.